Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.60 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.52 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.52 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | HTR2B | P41595 | 1/20 | 0.52 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.52 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.45 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667024 | 1.00 | SLC22A6 (0.60) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL13701365 | 0.95 | SLC22A6 (0.55) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL8292735 | 0.84 | SLC22A6 (0.60) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL976030 | 0.84 | SLC22A6 (0.60) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL976447 | 0.84 | SLC22A6 (0.60) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL6453593 | 0.83 | SLC22A6 (0.75) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL12327762 | 0.81 | SLC22A6 (0.50) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL12722973 | 0.81 | SLC22A6 (0.50) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL13800587 | 0.81 | SLC22A6 (0.50) | SLC22A6CACNA2D1CACNB3CACNA1CPGR | |
| SCHEMBL16600216 | 0.80 | SLC22A6 (0.55) | SLC22A6CACNA2D1CACNB3CACNA1CPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036190-B1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | CHIROBIO INC (KR) | 2005-05-11 | — | — | EP | claimed |
| US-6472188-B1 | SYNTHESIZING AND ACCUMULATING POLYHYDROXYALKANOATES (PHA) IN A CELL OF A MICROORGANISM BY CULTURING THE MICROORGANISM HAVING POLYHYDROXYALKANOATE DEPOLYMERASE ACTIVITY, COLLECTING CULTURED POLYMER, SUBJECTING TO MICROBIAL ENZYME DEGRADATION | CHIROBIO INC. (KR) | 2002-10-29 | — | — | US | claimed |
| EP-1036190-A1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | ChiroBio Inc. (KR) | 2000-09-20 | — | — | EP | claimed |
| WO-1999029889-A1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | LG CHEMICAL LTD. (KR) | 1999-06-17 | — | — | WO | claimed |
| US-9062028-B2 | Bicyclic nitrogen containing heteroaryl TGR5 receptor modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-06-23 | — | — | US | disclosed |
| US-20140080788-A1 | NOVEL BICYCLIC NITROGEN CONTAINING HETEROARYL TGR5 RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB COMPANY | 2014-03-20 | — | — | US | disclosed |
| WO-2008113190-A1 | METHOD FOR THE PRODUCTION OF R-HYDROXYCARBOXYLIC ACIDS | EMPA EIDGENÖSSISCHE MATERIALPRÜFUNGS- UND FORSCHUNGSANSTALT (CH) | 2008-09-25 | — | — | WO | disclosed |
| EP-1036190-B1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | CHIROBIO INC (KR) | 2005-05-11 | — | — | EP | disclosed |
| US-6472188-B1 | SYNTHESIZING AND ACCUMULATING POLYHYDROXYALKANOATES (PHA) IN A CELL OF A MICROORGANISM BY CULTURING THE MICROORGANISM HAVING POLYHYDROXYALKANOATE DEPOLYMERASE ACTIVITY, COLLECTING CULTURED POLYMER, SUBJECTING TO MICROBIAL ENZYME DEGRADATION | CHIROBIO INC. (KR) | 2002-10-29 | — | — | US | disclosed |
| EP-1036190-A1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | ChiroBio Inc. (KR) | 2000-09-20 | — | — | EP | disclosed |
| WO-1999029889-A1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | LG CHEMICAL LTD. (KR) | 1999-06-17 | — | — | WO | disclosed |
| EP-0387196-B1 | Complexes with optically active ligands, process for their preparation and their use | CIBA GEIGY AG (CH) | 1995-05-03 | — | — | EP | disclosed |
| US-5047557-A | Complexes having optically active ligands, a process for their preparation and their use | CIBA-GEIGY CORPORATION (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0387196-A1 | Complexes with optically active ligands, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1990-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140080788-A1 | NOVEL BICYCLIC NITROGEN CONTAINING HETEROARYL TGR5 RECEPTOR MODULATORS | GRK5, GPBAR1, GPR55 | SLC22A6 1327/4885CACNA2D1 3895/4885CACNB3 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.